Publications by authors named "Emmanuel Bache"

Claim this Profile
W
Which trial do we need? A randomised controlled study to compare the protective efficacy of early post-exposure discontinuation versus standard atovaquone-proguanil malaria prophylaxis in a human Plasmodium falciparum challenge model.
Jenny L Schnyder, Hanna K de Jong, Emmanuel B Bache, Reinier M van Hest, Sabine Bélard

Clin Microbiol Infect· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On the potential for discontinuing atovaquone-proguanil (AP) ad-hoc post-exposure and other abbreviated AP-regimens: Pharmacology, pharmacokinetics and perspectives.
Jenny L Schnyder, Hanna K de Jong, Emmanuel B Bache, Reinier M van Hest, Patricia Schlagenhauf

Travel Med Infect Dis· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complicated Odontogenic Infections at 2 District Hospitals in Tonkolili District, Sierra Leone: Protocol for a Prospective Observational Cohort Study (DELAY).
Hanna M J L Hazenberg, Jan Henk Dubbink, Issa Sesay, Tom Versteege, Hassan Bangura, Emmanuel B Bache

JMIR Res Protoc· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surveillance of the major pathogenic arboviruses of public health concern in Gabon, Central Africa: increased risk of West Nile virus and dengue virus infections.
Yuri Ushijima, Haruka Abe, Georgelin Nguema Ondo, Rodrigue Bikangui, Marguerite Massinga Loembé, Emmanuel B Bache

BMC Infect Dis· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in Gabonese adults: a randomised, controlled, double-blind, phase 1 dose-escalation trial.
Ayola A Adegnika, Sophia G de Vries, Frejus J Zinsou, Yabo J Honkepehedji, Jean-Claude Dejon Agobé, Emmanuel B Bache

Lancet Infect Dis· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study.
Angela Huttner, Selidji Todagbe Agnandji, Christophe Combescure, José F Fernandes, Emmanuel Bache Bache

Lancet Infect Dis· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial.
Selidji T Agnandji, José F Fernandes, Emmanuel B Bache, Régis M Obiang Mba, Jessica S Brosnahan

PLoS Med· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single-dose antihelminthic treatment does not influence immunogenicity of a meningococcal and a cholera vaccine in Gabonese school children.
Sina Brückner, Selidji Todagbe Agnandji, Johannes Elias, Stefan Berberich, Emmanuel Bache

Vaccine· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuberculosis Treatment Outcome and Drug Resistance in Lambaréné, Gabon: A Prospective Cohort Study.
Sabine Bélard, Jonathan Remppis, Sanne Bootsma, Saskia Janssen, Davy U Kombila, Emmanuel B Bache

Am J Trop Med Hyg· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Antihelminthic Treatment on Vaccine Immunogenicity to a Seasonal Influenza Vaccine in Primary School Children in Gabon: A Randomized Placebo-Controlled Trial.
Sina Brückner, Selidji T Agnandji, Stefan Berberich, Emmanuel Bache, José F Fernandes

PLoS Negl Trop Dis· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical development of RTS,S/AS malaria vaccine: a systematic review of clinical Phase I-III trials.
Selidji T Agnandji, José F Fernandes, Emmanuel B Bache, Michael Ramharter

Future Microbiol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe.
Selidji T Agnandji, Angela Huttner, Madeleine E Zinser, Patricia Njuguna, Christine Dahlke, Emmanuel B Bache

N Engl J Med· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The diagnostic accuracy of the hand-held Raman spectrometer for the identification of anti-malarial drugs.
Benjamin J Visser, Sophia G de Vries, Emmanuel B Bache, Janneke Meerveld-Gerrits, Daniëlle Kroon

Malar J· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the quality of anti-malarial drugs from Gabonese pharmacies using the MiniLab®: a field study.
Benjamin J Visser, Janneke Meerveld-Gerrits, Daniëlle Kroon, Judith Mougoula, Rieke Vingerling, Emmanuel Bache

Malar J· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis